Evidence Question
Do DPP-4 Inhibitors lower HbA1c?
Related to: DPP-4 InhibitorsShort answer
DPP-4 Inhibitors appear to lower HbA1c.
Evidence at a glance
- Evidence strength
- Emerging Evidence
- Supporting research
- 11 studys
- Randomized trials
- 11 trials
Why do we say this?
Across 11 randomized trials, the evidence showed an effect on HbA1c with DPP-4 Inhibitors.
Explore the evidence
Supporting research
11 published studys
- Vildagliptin improves insulin resistance and weight in type 2 diabetes
- Empagliflozin reduces HbA1c in youth with type 2 diabetes
- Vildagliptin and Metformin Improve Glycemic Control in Type 2 Diabetes
- Sitagliptin/Empagliflozin Improves Glycemic Control in Type 2 Diabetes
- Fotagliptin improves glycaemic control in type 2 diabetes patients
